Question 1

Is HAS-BLED a bleeding risk score that tells you to stop anticoagulation?

Accepted Answer

No. HAS-BLED is a bleeding risk score, not a stop rule. A high score should prompt correction of modifiable bleeding-risk factors and closer follow-up rather than withholding anticoagulation — withholding it usually removes stroke protection from the patients who need it most, because bleeding and stroke risk factors overlap heavily.

Question 2

What is a high HAS-BLED score?

Accepted Answer

A HAS-BLED score of 3 or more is generally considered high bleeding risk. Under the 2023 ACC/AHA/ACCP/HRS atrial fibrillation guideline, a score ≥3 should trigger correction of modifiable factors — blood pressure control, minimizing concurrent antiplatelets/NSAIDs, reducing alcohol, and improving INR time-in-therapeutic-range on warfarin — together with earlier and more frequent review.

Question 3

Does a high HAS-BLED score mean anticoagulation should be stopped?

Accepted Answer

No — this is the central point of the score, and the one most often misapplied. A high HAS-BLED does not contraindicate anticoagulation. The 2023 ACC/AHA/ACCP/HRS atrial fibrillation guideline retains HAS-BLED and recommends that a score ≥3 prompt correction of modifiable bleeding risk factors and earlier, more frequent review, not withholding therapy. The 2024 ESC guideline removed HAS-BLED altogether and no longer endorses any single structured bleeding-risk score, keeping only the principle that anticoagulation should not be withheld on the basis of bleeding-risk factors alone. Either way, withholding anticoagulation because of a high bleeding score typically removes stroke protection from exactly the patients who need it most.

Question 4

What are the components of HAS-BLED?

Accepted Answer

One point each for: Hypertension (uncontrolled, SBP >160), Abnormal renal function, Abnormal liver function, Stroke history, Bleeding history or predisposition, Labile INR (time in therapeutic range <60% on warfarin), Elderly (>65), Drugs (antiplatelets or NSAIDs), and Alcohol excess (≥8 drinks/week). Abnormal renal and liver function each score separately, and drugs and alcohol each score separately, giving a maximum of 9.

Question 5

Which HAS-BLED risk factors are modifiable?

Accepted Answer

The actionable ones are uncontrolled hypertension, labile INR (improve time-in-therapeutic-range or switch to a DOAC where appropriate), concurrent antiplatelet/NSAID use (stop if not essential), and excess alcohol. Non-modifiable factors — age, prior stroke, prior major bleeding, irreversible renal or liver disease — still inform how closely to follow the patient. The score's main clinical value is prompting review of the modifiable factors.

Question 6

How should HAS-BLED be used together with CHA₂DS₂-VASc?

Accepted Answer

They are a pair: CHA₂DS₂-VASc estimates stroke risk and decides whether anticoagulation is indicated, while HAS-BLED estimates bleeding risk and flags who needs modifiable factors corrected and closer follow-up. Because the two share many risk factors (age, hypertension, prior stroke), high-bleeding-risk patients are frequently also high-stroke-risk, and for most of them the net benefit still favours anticoagulation.

Question 7

What bleeding rate does each HAS-BLED score correspond to?

Accepted Answer

In the original Pisters 2010 (Euro Heart Survey) cohort, major bleeds per 100 patient-years were roughly 1.13 at 0, 1.02 at 1, 1.88 at 2, 3.74 at 3, and 8.70 at 4, rising further at ≥5. These absolute rates come from a specific cohort and vary in later validations, so they are best read as a gradient — risk rises with score — rather than precise probabilities for an individual.

Question 8

Does HAS-BLED apply to DOACs or only to warfarin?

Accepted Answer

It was originally validated in warfarin-treated patients, and the 'labile INR' component only applies to warfarin. The remaining items are relevant to any anticoagulant, and HAS-BLED is commonly applied to DOAC-treated patients, though its discrimination is modest. Its enduring role is less about a precise probability than about systematically prompting clinicians to find and fix correctable bleeding risk.

HAS-BLED Bleeding Risk Calculator

Risk Factors

About

Formula

Interpretation

References

FAQ

Related Calculators

HAS-BLED Score	Bleeds per 100 Patient-Years
0	1.13
1	1.02
2	1.88
3	3.74
≥ 4	High risk — close monitoring needed